3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
12
Neoplasms
9
Lung Neoplasms
8
Prostatic Neoplasms
7
Multiple Myeloma
7
Melanoma
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Lymphoma, Large B-Cell, Diffuse
6
Squamous Cell Carcinoma of Head and Neck
5
Rectal Neoplasms
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
5
Glioblastoma
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Interventions
Vinblastine
1
Nivolumab
1
Cyclophosphamide
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Childhood Solid Tumor
×
30 days
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled